PYPD
Polypid Ltd

929
Mkt Cap
$73.45M
Volume
23,199.00
52W High
$5.12
52W Low
$2.30
PE Ratio
-1.55
PYPD Fundamentals
Price
$4.59
Prev Close
$4.62
Open
$4.60
50D MA
$4.33
Beta
0.35
Avg. Volume
81,236.05
EPS (Annual)
-$2.09
P/B
3.06
Rev/Employee
$0.00
$67.17
Loading...
Loading...
News
all
press releases
PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $13.00 price objective on shares of PolyPid in a research report on Wednesday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
PolyPid (NASDAQ:PYPD) Releases Earnings Results, Misses Expectations By $0.07 EPS
PolyPid (NASDAQ:PYPD - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.07...
MarketBeat·1d ago
News Placeholder
PolyPid Q4 Earnings Call Highlights
PolyPid (NASDAQ:PYPD) said 2025 marked a pivotal year as the company completed its SHIELD II Phase 3 trial and moved D-PLEX100 into the final stages of regulatory preparation, while also advancing...
MarketBeat·1d ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Sees Large Decrease in Short Interest
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 19,282 shares, a drop of 71.7...
MarketBeat·15d ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Given Average Recommendation of "Moderate Buy" by Brokerages
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com reports...
MarketBeat·1mo ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 72.2% in December
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 63,411 shares, an...
MarketBeat·2mo ago
News Placeholder
PolyPid Appoints Brooke Story As Chairman Of Board
(RTTNews) - PolyPid Ltd. (PYPD), a late-stage biopharma company, Tuesday announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025...
Nasdaq News: Markets·2mo ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the firm, MarketBeat reports. One equities...
MarketBeat·2mo ago
News Placeholder
FY2025 Earnings Forecast for PolyPid Issued By HC Wainwright
PolyPid Ltd. (NASDAQ:PYPD - Free Report) - Equities research analysts at HC Wainwright decreased their FY2025 EPS estimates for PolyPid in a research note issued on Wednesday, November 12th. HC...
MarketBeat·3mo ago
News Placeholder
Roth Capital Issues Optimistic Estimate for PolyPid Earnings
PolyPid Ltd. (NASDAQ:PYPD - Free Report) - Stock analysts at Roth Capital raised their FY2025 EPS estimates for PolyPid in a research report issued on Thursday, November 13th. Roth Capital analyst B...
MarketBeat·3mo ago
<
1
2
...
>

Latest PYPD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.